Dapagliflozin Tablets 5 Mg – DAPILA 5

Dapagliflozin Tablets 5 Mg : A breakthrough in diabetes management and cardiovascular health.

DAPILA 5: The composition of Dapagliflozin 5mg contains an SGLT 2- sodium-glucose co-transporter-2 inhibitor that inhibits the reabsorption of glucose in the proximal convoluted tubule (PCT) in the kidneys, promotes glucose excretion from the body via urination, and helps to manage CV-associated type 2 diabetes.

Recommended By Specialists:
Endocrinologists: Primarily recommended for the management of Type 2 diabetes mellitus, particularly in overweight or obese patients, where both glycemic control and weight reduction are desired.
General Physicians: Commonly prescribed for Type 2 diabetes, especially in individuals who require blood sugar regulation along with support for weight management.
Cardiologists: Often preferred in the treatment of heart failure with reduced ejection fraction (HFrEF) to improve cardiac outcomes and reduce hospitalizations.

Key benefits of Dapagliflozin Tablets 5 Mg – DAPILA 5
Cardioprotective and nephroprotective benefits: IT is suitable for the management of cardiovascular-associated type 2 diabetes and diabetes with CKD.
Significant action: To weight loss and weight neutrality in overweight and obesity patients due to diabetes.
Once daily dosage: To enhance patient compliance with a better safety profile, as it has a lower risk of hypoglycemia as compared to sulfonylurea derivatives (glipizide, glimepiride)

INDICATIONS:
Type 2 diabetes
Weight management
Type 2 diabetes with CKD
Type 2 diabetes with cardiovascular disease